A study has shown promise for effective treatment of therapy-resistant cancers caused by a mutation of the RAS gene found in many cancers. The pre-clinical study combined therapies targeting the inhibitors polyADP ribose polymerase (PARP) and mitogen-activated protein kinase (MEK).
from Top Health News – ScienceDaily http://bit.ly/2rGZMn4
from Tumblr http://bit.ly/2rqFP3b
No comments:
Post a Comment